Departament de Nutrició, Ciències de l'Alimentació i Gastronomía, Facultat de Farmàcia i Ciències de l'Alimentació, Campus de l'Alimentació de Torribera, Universitat de Barcelona (UB), Av. Prat de la Riba 171, 08921 Santa Coloma de Gramenet, Spain.
Institut de Recerca en Nutrició i Seguretat Alimentària (INSA·UB), Universitat de Barcelona (UB), Av. Prat de la Riba 171, 08921 Santa Coloma de Gramenet, Spain.
Nutrients. 2022 Apr 23;14(9):1774. doi: 10.3390/nu14091774.
An underlying cause of histamine intolerance is diamine oxidase (DAO) deficiency, which leads to defective homeostasis and a higher systemic absorption of histamine. Impaired DAO activity may have a genetic, pharmacological or pathological origin. A recent proposal also suggests it can arise from an alteration in the gut microbiota, although only one study has explored this hypothesis to date. A greater abundance of histamine-secreting bacteria in the gut could lead to the development of histamine intolerance. Thus, the aim of this study was to characterize the composition of the intestinal microbiota of patients with histamine intolerance symptoms and compare it with that of healthy individuals. The study was performed by sequencing bacterial 16S rRNA genes (V3-V4 region) and analyzing the data using the EzBioCloud Database. Dysbiosis of the gut microbiota was observed in the histamine intolerance group who, in comparison with the healthy individuals, had a significantly lower proportion of , , and , which are bacteria related to gut health. They also had a significantly higher abundance of histamine-secreting bacteria, including the genera and , several unidentified genera belonging to the family and the species and . A greater abundance of histaminogenic bacteria would favor the accumulation of high levels of histamine in the gut, its subsequent absorption in plasma and the appearance of adverse effects, even in individuals without DAO deficiency.
组胺不耐受的一个潜在原因是二胺氧化酶(DAO)缺乏,这导致了体内平衡的缺陷和组胺的全身性更高吸收。DAO 活性的损害可能具有遗传、药理学或病理学的起源。最近的一项建议还表明,它可能源于肠道微生物群的改变,尽管迄今为止只有一项研究探讨了这一假设。肠道中产生组胺的细菌数量增加可能导致组胺不耐受的发展。因此,本研究旨在描述组胺不耐受症状患者的肠道微生物群组成,并将其与健康个体进行比较。该研究通过测序细菌 16S rRNA 基因(V3-V4 区)并使用 EzBioCloud 数据库分析数据来进行。在组胺不耐受组中观察到肠道微生物群的失调,与健康个体相比,他们的 、 、 和 的比例明显较低,这些菌与肠道健康有关。他们还具有更高丰度的产生组胺的细菌,包括 和 属、几个属于 科的未鉴定属以及 和 种。更多的产组胺细菌会有利于肠道中组胺水平的积累,随后在血浆中吸收,以及出现不良反应,即使在没有 DAO 缺乏的个体中也是如此。